
Mumps cases triple in England
pharmafile | May 24, 2019 | News story | Medical Communications | MMR, UK, Vaccine, health, public health
Public Health England has urged patients to ensure that they have received the MMR vaccine after the number of cases of mumps almost tripled.
Mumps cases increased from 275 in the first quarter of 2018 to 795 cases in the first quarter of 2019. There were just 1,031 cases of mumps in the whole of 2018.
Large outbreaks occurred at The University of Nottingham and Nottingham Trent University at the beginning of the year.
Many students now at university were born at the peak of the MMR vaccine autism scare which saw immunisation rates drop in the UK and around the world.
Cases of measles have also more than doubled since the least quarter of 2019 increasing from 97 cases in Q4 2018 to 231 in Q1 2019. However measles cases spiked in Q2 2018 reaching a total of 421.
Public Health England urged healthcare professionals to speak ‘confidently about the value of vaccines’ as they said their research showed 93% of parents agreed that they were the most trusted source of information on vaccines.
Chief Executive at Public Health England, Duncan Selbie said: “In a world where mis-information is so easily spread online we must all speak confidently about the value of vaccines and leave the public in no doubt that they are safe and save lives.”
“It’s testament to our hard-working doctors and nurses that families trust them to provide accurate facts about the effectiveness of vaccines. They’re our vaccine heroes and we all have a role in supporting them.”
Louis Goss
Related Content

BioNet receives positive EMA opinion on new pertussis vaccine
BioNet has received a positive opinion from the Committee for Medicinal Products for Human Use …

Recipharm offers manufacturing support to vaccine trial from ImmBIO and iiCON
Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based …

EMA lifts temporary ban on chikungunya vaccine Ixchiq following safety review
After completing a safety review of Ixchiq – a vaccine for chikungunya – the European …






